Empagliflozin Attenuates Arrhythmias in an iPSC-Based Model of Hypertrophy Cardiomyopathy

Affiliations

• ¹ Department of Cardiothoracic Surgery, Stanford University School of Medicine, CA. (J.A.A., I.P.-G., V.T., N.V., R.R., A.A.G., I.K.).
• ² Stanford Cardiovascular Institute, Stanford University School of Medicine, CA. (J.A.A., N.B., I.P.-G., V.T., N.V., P.G., R.R., A.A.G., J.C.W., I.K.).
• ³ Department of Medicine, Stanford University School of Medicine, CA. (N.B., P.G., J.C.W.).
• ⁴ ICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Badalona, Spain (S.R., C.G.-M., A.B.-G.).
• ⁵ CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain (S.R., C.G.-M., A.B.-G.).
• ⁶ Faculty of Medicine, University of Vic-Central University of Catalonia, Spain (S.R.).
• ⁷ Cardiology Service, Germans Trias i Pujol University Hospital, Badalona, Spain (A.B.-G.).
• ⁸ Department of Medicine, Universitat Autònoma de Barcelona, Spain (A.B.-G.).